PRESS LAB

Oliver Press and Nancy Press will receive the Lymphoma Research Foundation Distinguished Service Award in New York on September 28, 2017 

Dr. Oliver Press honored as new Giuliani/Press Endowed Chair

Dr. Oliver Press honored with 2017 Dr. Ali Al-Johani Award

Dr. Oliver Press named 2017 Leader in Health Care by Seattle Business Magazine

Dr. Oliver Press portrait unveiled, mentorship award announced

UW establishes Dr. Oliver W. Press Distinguished MSTP Alumnus Award - Video interview with Oliver W. Press MD PhD and Nancy Ottman Press MA MLibr

The Press Lab at the Fred Hutchinson Cancer Research Center is devoted to the investigation of novel treatments for hematologic malignancies including non-Hodgkin's lymphoma, leukemia, and myeloma. We conduct basic laboratory investigations using leukemia and lymphoma cell lines and mouse xenograft models as well as human clinical trials. Agents currently under investigation include monoclonal antibodies, radioimmunoconjugates, immunotoxins, chemotherapeutic agents, and genetically modified cytotoxic T lymphocytes. In the clinical arena, we are continuing our successful program of high dose radioimmunotherapy with stem cell transplantation for B cell lymphomas and have trials planned investigating pretargeted radioimmunotherapy and gene therapy using adoptively transferred cytotoxic T lymphocytes bearing chimeric anti-CD20 receptors.